Inside Oncology: Lenvatinib and Lenalidomide Approved, New Agent Promising in Myeloma, and More

Approval of lenvatinib for differentiated thyroid cancer, the approval of frontline lenalidomide and positive findings for ixazomib in multiple myeloma, and a newly launched oncology care model by Med... Author: onclivetv Added: 02/25/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts